CA2011452A1 - Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one - Google Patents

Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one

Info

Publication number
CA2011452A1
CA2011452A1 CA2011452A CA2011452A CA2011452A1 CA 2011452 A1 CA2011452 A1 CA 2011452A1 CA 2011452 A CA2011452 A CA 2011452A CA 2011452 A CA2011452 A CA 2011452A CA 2011452 A1 CA2011452 A1 CA 2011452A1
Authority
CA
Canada
Prior art keywords
compound
pregn
hydroxy
methyl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2011452A
Other languages
English (en)
Other versions
CA2011452C (fr
Inventor
Gerard Arnoud Jozef Maria Theresia Sas
Emile Martin Van Doornum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2011452(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo NV filed Critical Akzo NV
Publication of CA2011452A1 publication Critical patent/CA2011452A1/fr
Application granted granted Critical
Publication of CA2011452C publication Critical patent/CA2011452C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002011452A 1989-03-18 1990-03-05 Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one Expired - Lifetime CA2011452C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL89.00673 1989-03-18
NL8900673 1989-03-18

Publications (2)

Publication Number Publication Date
CA2011452A1 true CA2011452A1 (fr) 1990-09-18
CA2011452C CA2011452C (fr) 1999-05-25

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002011452A Expired - Lifetime CA2011452C (fr) 1989-03-18 1990-03-05 Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one

Country Status (17)

Country Link
US (1) US5037817A (fr)
EP (1) EP0389035B1 (fr)
JP (2) JP3139709B2 (fr)
KR (1) KR0183401B1 (fr)
AT (1) ATE98490T1 (fr)
AU (1) AU625083B2 (fr)
CA (1) CA2011452C (fr)
DE (1) DE69005165T2 (fr)
DK (1) DK0389035T3 (fr)
ES (1) ES2062292T3 (fr)
FI (1) FI94865C (fr)
HK (1) HK1002019A1 (fr)
IE (1) IE63051B1 (fr)
MX (1) MX9203787A (fr)
NZ (1) NZ232946A (fr)
PT (1) PT93488B (fr)
ZA (1) ZA901674B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0613687B1 (fr) * 1993-03-05 1999-06-02 Akzo Nobel N.V. Utilisation des dérivés de pregnane pour le traitement des tumeurs
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
JP2002527525A (ja) * 1998-10-16 2002-08-27 アクゾ・ノベル・エヌ・ベー （７α，１７α）−１７−ヒドロキシ−７−メチル−１９−ノル−１７−プレグヌ−５（１０）−エン−２０−イン−３−オンを含む高純度組成物
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
CA2332767A1 (fr) * 1999-03-18 2000-09-21 Genelabs Technologies, Inc. Composition de dhea et procede
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
ATE364619T1 (de) * 2001-10-18 2007-07-15 Norton Healthcare Ltd Tibolonformulierungen
RU2004125594A (ru) * 2002-01-22 2005-03-10 Акцо Нобель Н.В. (NL) Применение тиболона при лечение симптомов, связанных с введением лекарств, препятствующих синтезу эндогенного эстрогена
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
ES2243919T3 (es) * 2003-05-23 2005-12-01 Akzo Nobel N.V. Formulacion solida farmaceutica que contiene tibolona.
EP1883648A1 (fr) * 2005-05-23 2008-02-06 Newchem S.p.A. Procede de preparation de tibolone cristalline pure
EP1821571A1 (fr) * 2006-02-15 2007-08-22 Oticon A/S Antenne à boucle pour dispositif d'écouteur intra-auriculaire
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
MX381207B (es) 2016-05-04 2025-03-12 Novalon S A Uso de alcoholes de azucar en composiciones de tibolona

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (fr) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
FI901328A0 (fi) 1990-03-16
IE63051B1 (en) 1995-03-22
ES2062292T3 (es) 1994-12-16
EP0389035B1 (fr) 1993-12-15
US5037817A (en) 1991-08-06
FI94865B (fi) 1995-07-31
ZA901674B (en) 1990-12-28
JPH0347195A (ja) 1991-02-28
KR900013950A (ko) 1990-10-22
ATE98490T1 (de) 1994-01-15
IE900709L (en) 1990-09-18
EP0389035A1 (fr) 1990-09-26
CA2011452C (fr) 1999-05-25
PT93488A (pt) 1990-11-07
FI94865C (fi) 1995-11-10
DE69005165D1 (de) 1994-01-27
HK1002019A1 (en) 1998-07-24
JP3139709B2 (ja) 2001-03-05
NZ232946A (en) 1991-08-27
AU625083B2 (en) 1992-07-02
DE69005165T2 (de) 1994-05-05
KR0183401B1 (ko) 1999-05-01
JP2001139473A (ja) 2001-05-22
MX9203787A (es) 1992-07-01
DK0389035T3 (da) 1994-02-14
PT93488B (pt) 1996-02-29
AU5139490A (en) 1990-09-20

Similar Documents

Publication Publication Date Title
AU625083B2 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one
AU660321B2 (en) 1,2-dihydro-2-oxopyridine
AU3884589A (en) Intravenous pharmaceutical composition comprising cyclosporins
AU7360887A (en) Pharmacologically active 1,5-diarly-3-substituted- pyrazoles and method for synthesizing the same
USD310249S (en) Bingo card marker
AU6290090A (en) Bi-or trispecific (fab)3 or (fab)4 conjugates
AU3815589A (en) Energy-curable cyanate compositions
AU2992689A (en) 2',3'-dideoxy-2',2'-difluoronucleosides
AU2710892A (en) Cytotoxic bicyclo (7.3.1) tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
AU2868789A (en) 1,4-disubstituted-piperidinyl compounds
AU3782889A (en) New substituted 1, 7-annelated 1h-indazoles
AU6168190A (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
AU4717089A (en) N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas
AU4430989A (en) Compound, composition, process and use
AU5229690A (en) Polyamide 4.6 composition
NO912992L (no) 1-aminopropandiol-2,3 med hoey renhet, samt fremgangsmaate for fremstilling av forbindelsen.
EP0352085A3 (en) Electron microscope
OA09192A (en) "Stabilized sulfur dissolving compositions".
AU2948189A (en) 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
AU5388090A (en) N-sulfenyl- and n-sulfinyl-n,n'-diacylhydrazides
CA2018461A1 (fr) Polypeptides et leur utilisation
AU2831392A (en) Substituted 1, 5-pentanediols and processes for the preparation thereof
AU1072888A (en) 3-aryl-5-alkylthio-4H-1,2,4-thiazoles
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
AU2681888A (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry